AAME vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

AAME

39.0
AI Score
VS
BBIO Wins

BBIO

51.8
AI Score

Investment Advisor Scores

AAME

39score
Recommendation
SELL

BBIO

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAME BBIO Winner
Revenue 159.18M 438.19M BBIO
Net Income 4.70M -322.45M AAME
Net Margin 2.9% -73.6% AAME
ROE 4.3% 12.8% BBIO
ROA 1.1% -26.5% AAME
Total Assets 430.86M 1.22B BBIO
Cash 34.44M 677.91M BBIO
Free Cash Flow 14.73M -268.89M AAME

Relative Price Performance (Last 90 Days)

AAME 1M: -12.3% · 3M: -39.7% BBIO 1M: -1.7% · 3M: +16.0%

Current Technical Phase

AAME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.7%), weak momentum, RSI 31

RSI (14): 31.4 · Price: $1.35

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.9 · Price: $81.50

Fundamentals Snapshot

Metric AAME BBIO
Market Cap
Forward P/E 7.4 532.0
Trailing P/E 5.8
Revenue (TTM)
Revenue Growth 0.2% 1.2%
Gross Margin 0.1% 0.9%
Operating Margin 0.0% -0.4%
EPS 0.23 -3.52
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.